Search
Skip to Search Results- 11Heart failure
- 6Telehealth
- 2Cardiac resynchronization therapy
- 2Energy metabolism
- 12-methoxyestradiol
- 1AE3
- 1Allana, Saleema Mansoor
- 1Alma'ayah, Zaid H
- 1Almajed, Nawaf S
- 1Anderson, Todd J.
- 1Barlow, Ingrid
- 1Becher, Harald
- 11Graduate and Postdoctoral Studies (GPS), Faculty of
- 11Graduate and Postdoctoral Studies (GPS), Faculty of/Theses and Dissertations
- 2Nursing, Faculty of
- 1Toolkit for Grant Success
- 1Toolkit for Grant Success/Educational Materials (Toolkit for Grant Success)
- 1Equity Diversity Inclusion Community (EDI)
-
Setting the Tone for Virtual Spasticity Assessment: Planning Development and Testing of the Telerehabilitation-Objective-Neuromuscular- Evaluation (TONE) Device
DownloadSpring 2024
Background: Telehealth provides the ability to connect specialist healthcare providers with patients regardless of geographical location or other limitations restricting in-person care. Spasticity is a common complication affecting individuals with neurological conditions requiring specialist...
-
Using Intersectionality Theory and Critical Realism for Exploring Heart Failure Telehealth Interventions for Vulnerable Patient Populations: A Scoping Review, Intersectionality-based Analysis, and A Rapid Realist Review
DownloadFall 2022
Background: Heart Failure (HF) is at epidemic levels among older adults, globally. Heart Failure Disease Management Interventions (HFDMIs) enhance self-care and quality of life as well as reduce hospital readmissions, through patient education and follow up, effective treatment, psychosocial...
-
Fall 2021
One third of all deaths in Canada are due to cardiovascular diseases, including heart failure. Cardiovascular diseases have a considerable economic burden, and drastically impact the health and quality of life of Canadians. Heart failure (HF) is a clinical condition where the heart is unable to...
-
The role of cytochrome P450 1B1 and its associated metabolites in the pathogenesis of cardiac hypertrophy and drug-induced heart failure
DownloadFall 2018
Heart failure (HF) is one of the most widespread and lethal forms of heart disease worldwide. Most HF patients have a history of hypertension and left ventricular hypertrophy in addition to drug-induced cardiotoxicity. Mechanisms regulating cardiac hypertrophy and drug-induced HF have been the...
-
Multiple Outcomes in Heart Failure Research: Composite Endpoints and Multivariate Modelling
DownloadFall 2017
Composite endpoints are increasingly popular outcomes in clinical trials of heart failure. Uptake has outpaced guidance on their use and little consistency is seen in their construction. We must consider how best to handle multiple outcomes statistically and clinically, ie in a way that is both...
-
Fall 2016
Abstract Aims: The use of telehealth for heart failure management is increasing and it is not clear from the literature whether it is more beneficial than usual care. A meta-analysis was done of published randomized controlled trials to compare telehealth management and usual physician care for...
-
Spring 2016
Heart failure is associated with major changes in cardiac energy metabolism that decrease cardiac efficiency, which can reduce cardiac function. In severe heart failure there is a shift back toward a fetal heart metabolism, with a decrease in mitochondrial oxidative metabolism and increase in...
-
Structure and Function of Cardiac Troponin C (TNNC1): Implications for Heart Failure, Cardiomyopathies, and Troponin Modulating Drugs
Download2015-01-01
Li, Monica X., Hwang, Peter M.
In striated muscle, the protein troponin complex turns contraction on and off in a calcium-dependent manner. The calcium-sensing component of the complex is troponin C, which is expressed from the TNNC1 gene in both cardiac muscle and slow-twitch skeletal muscle (identical transcript in both...
-
2014-11-05
Thompson, Richard B., Oudit, Gavin Y., Paterson, D. Ian, Becher, Harald, Kaul, Padma, Knudtson, Merril L., Dyck, Jason R.B., Lopaschuk, Gary D., Belenkie, Israel, Clark, Alexander M., Schulz, Richard, Howlett, Jonathan G., Kim, Daniel H., Anderson, Todd J., Weeks, Sarah G., Haykowsky, Mark J., McAlister, Finlay A., Ezekowitz, Justin A., Friedrich, Matthias G., Quan, Hude, Duff, Henry J., Noga, Michelle L., Kassiri, Zamaneh, Light, Peter E.
Nationally, symptomatic heart failure affects 1.5-2% of Canadians, incurs $3 billion in hospital costs annually and the global burden is expected to double in the next 1–2 decades. The current one-year mortality rate after diagnosis of heart failure remains high at >25%. Consequently, new...